Trevena Stock Forecast, Price & News

Trevena (NASDAQ:TRVN) Frequently Asked Questions

Is Trevena a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trevena in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Trevena stock.
View analyst ratings for Trevena or view top-rated stocks.

How has Trevena's stock been impacted by COVID-19 (Coronavirus)?

Trevena's stock was trading at $0.6984 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TRVN stock has decreased by 25.8% and is now trading at $0.5180.
View which stocks have been most impacted by COVID-19.

When is Trevena's next earnings date?

Trevena is scheduled to release its next quarterly earnings announcement on Tuesday, March 8th 2022.
View our earnings forecast for Trevena.

How were Trevena's earnings last quarter?

Trevena, Inc. (NASDAQ:TRVN) issued its earnings results on Monday, November, 15th. The biopharmaceutical company reported ($0.08) EPS for the quarter, topping the Zacks' consensus estimate of ($0.09) by $0.01. The biopharmaceutical company earned $0.18 million during the quarter, compared to analyst estimates of $1.16 million. Trevena had a negative trailing twelve-month return on equity of 53.47% and a negative net margin of 7,771.74%. During the same quarter in the prior year, the firm earned ($0.04) earnings per share.
View Trevena's earnings history.

What price target have analysts set for TRVN?

2 brokerages have issued 1 year target prices for Trevena's stock. Their forecasts range from $6.00 to $6.00. On average, they expect Trevena's share price to reach $6.00 in the next year. This suggests a possible upside of 1,058.3% from the stock's current price.
View analysts' price targets for Trevena or view top-rated stocks among Wall Street analysts.

Who are Trevena's key executives?

Trevena's management team includes the following people:

• Carrie L. Bourdow, President, Chief Executive Officer & Director (LinkedIn Profile)
• Barry Shin, Chief Financial Officer & Senior Vice President
• Mark A. Demitrack, Chief Medical Officer & Senior Vice President
• Angela Bagley, Vice President-Technical Operations
• Michael J. Fossler, VP-Clinical Development & Quantitative Sciences

Who are some of Trevena's key competitors?

Some companies that are related to Trevena include Applied Molecular Transport (AMTI), Geron (GERN), BioDelivery Sciences International (BDSI), Omeros (OMER), Avadel Pharmaceuticals (AVDL), Adagene (ADAG), Vaccitech (VACC), AC Immune (ACIU), Immuneering (IMRX), Nanobiotix (NBTX), Pyxis Oncology (PYXS), XBiotech (XBIT), Radius Health (RDUS), Cogent Biosciences (COGT) and Sernova (SEOVF).
View all of TRVN's competitors.

What other stocks do shareholders of Trevena own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trevena investors own include Conatus Pharmaceuticals (CNAT), Novavax (NVAX), Sorrento Therapeutics (SRNE), ADMA Biologics (ADMA), SCYNEXIS (SCYX), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Aeterna Zentaris (AEZS), Bionano Genomics (BNGO) and Dynavax Technologies (DVAX).

What is Trevena's stock symbol?

Trevena trades on the NASDAQ under the ticker symbol "TRVN."

How do I buy shares of Trevena?

Shares of TRVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trevena's stock price today?

One share of TRVN stock can currently be purchased for approximately $0.52.

How much money does Trevena make?

Trevena has a market capitalization of $85.22 million and generates $3.07 million in revenue each year. The biopharmaceutical company earns $-29.37 million in net income (profit) each year or ($0.31) on an earnings per share basis.

How many employees does Trevena have?

Trevena employs 25 workers across the globe.

What is Trevena's official website?

The official website for Trevena is www.trevena.com.

Where are Trevena's headquarters?

Trevena is headquartered at 955 Chesterbrook Boulevard Suite 110, Chesterbrook PA, 19087.

How can I contact Trevena?

Trevena's mailing address is 955 Chesterbrook Boulevard Suite 110, Chesterbrook PA, 19087. The biopharmaceutical company can be reached via phone at (610) 354-8840 or via email at [email protected].